XIKANG CLOUD (09686) Deploys US$15.41 million Idle IPO Proceeds into Low-Risk Shenwan Hongyuan Structured Note

Bulletin Express
Yesterday

XIKANG CLOUD HOSPITAL HOLDINGS INC. (09686) has reinvested US$15.41 million of idle funds from its 2023 global offering into a new wealth-management product issued by Shenwan Hongyuan Financial Products Company Limited.

The new instrument, a “Fund Portfolio Linked Note,” was subscribed on 13 March 2026 using the full principal and returns generated from a previous one-year placement that matured on the same date. Key terms are as follows:

• Principal subscribed: US$15.41 million • Product type: Guaranteed structured note with Shenwan Hongyuan (H.K.) acting as guarantor • Internal risk rating: Low • Tenor: One year, subject to early redemption at any time • Expected annualised return: 2.25%–3.75%

Under Hong Kong Listing Rule 14.07, at least one applicable percentage ratio exceeds 5% but is below 25%, classifying the deal as a discloseable transaction requiring public announcement but not shareholder approval.

The board cited three primary benefits of the move: enhanced utilisation of idle proceeds, preservation of capital through low-risk assets, and flexible liquidity management without impacting the group’s operating cash.

XIKANG CLOUD operates a cloud-hospital network that connects local governments, medical institutions, patients and insurers for integrated medical, nursing and health-management services.

Both Shenwan Hongyuan Financial Products and Shenwan Hongyuan (H.K.) are independent of XIKANG CLOUD and its connected persons.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10